Emergent BioSolutions was awarded a contract worth about $54 million to supply the Administration for Strategic Preparedness and Response with additional doses of Vigiv, a treatment for smallpox ...

Recurring order from an undisclosed European country to strengthen public preparedness. Combined with other recent orders from non-European countries, the Company has now secured above DKK 3,000 ...

Submission based on topline data from clinical study, demonstrating a comparable safety profile and a non-inferior immune ...

Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured a contract award valued at approximately $54 million USD to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV ...

Defending COVID-19 policies against legal challenges, government officials relied heavily on Jacobson v. Massachusetts, a 1905 case in which the U.S. Supreme Court upheld a smallpox vaccine mandate ...

Add Yahoo as a preferred source to see more of our stories on Google. William Foege, the mastermind behind the world’s eradication of smallpox, died aged 89. The disease was among the world’s ...

In the event of a bioterror attack using smallpox, health authorities could stretch out the nation's limited vaccine supply simply by diluting the 15 million doses ...

Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme disease ...

Bavarian Nordic files clinical data to EMA to extend mpox and smallpox vaccine approval to children aged from 2 to 11 years: Copenhagen, Denmark Saturday, March 28, 2026, 12:00 Hr ...

Dive into how fear of smallpox reshaped societies long before vaccines turned the tide 💉🛡️. This short history peels back ...